Tag "biotech stocks"

An Inside Look At The Rally In Biotech and Pharmaceutical Stocks

Last fall, we laid out the foundation for the current rally in pharmaceutical and biotech stocks; we take stock of those setups and the sectors’ present prospects. Some may construe today’s post – and the associated charts of the day – as a victory lap. And while there may be…

Sector Update: Health Care and Biotech Stocks Hot

I recommended the Health Care Sector ETF (NYSEARCA:XLV) in my June 8th “On The Mark” newsletter, predicting a short-term move up to the 79/80 area. Today we’ll provide an update while looking at the red-hot biotech sector (NASDAQ:IBB) as well. XLV is now trading at 79.63 for a 3.8% gain in…

Compression Signal Says Biotech Stocks Poised For Huge Move

“Timing the market is a fool’s game.” We hear this all the time. However, the notion that markets are efficient is a fallacy. Markets are driven by human emotion: bubbles form and pop as euphoria turns to panic. From Tulip Mania in the 1630’s to the Dot Com Bubble in…

Inside The Markets: 5 Charts For Active Investors (February 22)

It’s time for another round of macro technical charts as investors attempt to weigh the risk to reward ratio across several markets (including stock market indices, sectors, individual commodities, currencies, bonds, and other benchmarks and market indicators). This chart review will look at 5 charts with important technical price developments.  Even if you’re not…

Biotech ETF (XBI) On The Brink Of A Breakout

The volatility in the biotech space over the last two years has been quite a sight to behold. I’m not strictly speaking of volatility in terms of downside either. There has been money to be made on both sides of the market for those that have been nimble in their…

5 Charts To Watch This Week: Breakouts & Divergences!

It’s time for another set of macro technical charts to watch as we prepare for the month of February (including stock market indices, sectors, individual commodities, currencies, bonds, and other benchmarks and market indicators). This chart review will include 5 charts and look at key technical price developments.  Even if you’re…

Biotech Sector (IBB): A Closer Look At The 2017 Rally

The Nasdaq Biotechnology ETF (NASDAQ:IBB) saw a knee-jerk reaction lower Wednesday after President-elect Donald Trump made harsh comments about drug pricing. On Wednesday, it finished off by -2.99%. While that decline was sharp, and may have hit a few traders, there was a silver lining for opportunistic traders (and I shared this yesterday on my…

Biotechnology Sector Testing Bull Market Trendline

When this market cycle finally comes to an end, among the sectors that will be remembered as one of its key drivers is biotechnology. With a gaudy 750% gain since its 2009 lows, the Biotech run had been so hot, it attracted “bubble” talk in its descriptions, including by us back…

Gilead Sciences (GILD): Fundamentals vs Technicals

About $7 ago, I tweeted that Gilead Sciences stock (NASDAQ:GILD) was starting to present a real conundrum of fundamentals/valuation (positive) vs. technicals (negative). So far the technicals (and specifically DeMark indicators) have prevailed. But ignoring Gilead Sciences stock fundamentals (valuation and balance sheet) is becoming increasingly difficult. If you are…